Mycosis fungoides

Association of KIR ligands and HLA-DQB1∗05 with bad prognosis of the disease

V. Brazzelli, N. Rivetti, C. Badulli, A. Carugno, R. Cananzi, A. De Silvestri, M. Martinetti, G. Borroni

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma. We previously reported that the prognosis of MF patients is not only related on clinical variables but it is also associated with peculiar HLA alleles. Until today, the association of HLA ligands for KIR with the prognosis of the disease has not yet been analysed. Objective We investigated the frequency of HLA ligands for killer cell Immunoglobulin-like receptors (KIRs) in MF patients, evaluating if the presence of particular HLA alleles that are ligands for KIR may have prognostic value. Methods The study includes 46 Caucasian MF patients that, between 1993 and 1997, underwent HLA genomic typing. All patients were diagnosed and followed up from 1977 to 2012 (mean follow-up of 11 years). Results MF patients have been divided into two groups (long survivors and dead patients). We noticed that the HLA-Bw6/Bw6 specificity increased among the group of seven dead patients compared to the group of 39 long survivors (71.4% vs. 41.0%, P = ns, OR = 3.59), while in the long survivors group the HLA- Bw4/Bw4 specificity increased when compared to dead patients (23.0% vs. 0%, P = ns). Moreover, we observed that six of the seven dead patients had HLA-DQB1∗05; the phenotypic frequency of this HLA allele, in dead and long survivors patients, was 85.7% and 23.0% respectively (P = 0.004; OR = 20). Conclusion Our observations suggest that the presence of the HLA-DQB1∗05 alleles characterizes the patients with the poorest prognosis in MF. In addition, absence of the KIR-ligand epitope HLA-B Bw4 showed a trend of being more prominent in MF patients with the poorest prognosis.

Original languageEnglish
Pages (from-to)266-269
Number of pages4
JournalJournal of the European Academy of Dermatology and Venereology
Volume30
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

KIR Receptors
Mycosis Fungoides
Ligands
Survivors
Alleles
Cutaneous T-Cell Lymphoma
Histocompatibility Testing
HLA-B Antigens
Gene Frequency
Epitopes

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

Mycosis fungoides : Association of KIR ligands and HLA-DQB1∗05 with bad prognosis of the disease. / Brazzelli, V.; Rivetti, N.; Badulli, C.; Carugno, A.; Cananzi, R.; De Silvestri, A.; Martinetti, M.; Borroni, G.

In: Journal of the European Academy of Dermatology and Venereology, Vol. 30, No. 2, 01.02.2016, p. 266-269.

Research output: Contribution to journalArticle

@article{9bd79b68f0764683abf39f93ae6a9930,
title = "Mycosis fungoides: Association of KIR ligands and HLA-DQB1∗05 with bad prognosis of the disease",
abstract = "Background Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma. We previously reported that the prognosis of MF patients is not only related on clinical variables but it is also associated with peculiar HLA alleles. Until today, the association of HLA ligands for KIR with the prognosis of the disease has not yet been analysed. Objective We investigated the frequency of HLA ligands for killer cell Immunoglobulin-like receptors (KIRs) in MF patients, evaluating if the presence of particular HLA alleles that are ligands for KIR may have prognostic value. Methods The study includes 46 Caucasian MF patients that, between 1993 and 1997, underwent HLA genomic typing. All patients were diagnosed and followed up from 1977 to 2012 (mean follow-up of 11 years). Results MF patients have been divided into two groups (long survivors and dead patients). We noticed that the HLA-Bw6/Bw6 specificity increased among the group of seven dead patients compared to the group of 39 long survivors (71.4{\%} vs. 41.0{\%}, P = ns, OR = 3.59), while in the long survivors group the HLA- Bw4/Bw4 specificity increased when compared to dead patients (23.0{\%} vs. 0{\%}, P = ns). Moreover, we observed that six of the seven dead patients had HLA-DQB1∗05; the phenotypic frequency of this HLA allele, in dead and long survivors patients, was 85.7{\%} and 23.0{\%} respectively (P = 0.004; OR = 20). Conclusion Our observations suggest that the presence of the HLA-DQB1∗05 alleles characterizes the patients with the poorest prognosis in MF. In addition, absence of the KIR-ligand epitope HLA-B Bw4 showed a trend of being more prominent in MF patients with the poorest prognosis.",
author = "V. Brazzelli and N. Rivetti and C. Badulli and A. Carugno and R. Cananzi and {De Silvestri}, A. and M. Martinetti and G. Borroni",
year = "2016",
month = "2",
day = "1",
doi = "10.1111/jdv.13083",
language = "English",
volume = "30",
pages = "266--269",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "wiley",
number = "2",

}

TY - JOUR

T1 - Mycosis fungoides

T2 - Association of KIR ligands and HLA-DQB1∗05 with bad prognosis of the disease

AU - Brazzelli, V.

AU - Rivetti, N.

AU - Badulli, C.

AU - Carugno, A.

AU - Cananzi, R.

AU - De Silvestri, A.

AU - Martinetti, M.

AU - Borroni, G.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Background Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma. We previously reported that the prognosis of MF patients is not only related on clinical variables but it is also associated with peculiar HLA alleles. Until today, the association of HLA ligands for KIR with the prognosis of the disease has not yet been analysed. Objective We investigated the frequency of HLA ligands for killer cell Immunoglobulin-like receptors (KIRs) in MF patients, evaluating if the presence of particular HLA alleles that are ligands for KIR may have prognostic value. Methods The study includes 46 Caucasian MF patients that, between 1993 and 1997, underwent HLA genomic typing. All patients were diagnosed and followed up from 1977 to 2012 (mean follow-up of 11 years). Results MF patients have been divided into two groups (long survivors and dead patients). We noticed that the HLA-Bw6/Bw6 specificity increased among the group of seven dead patients compared to the group of 39 long survivors (71.4% vs. 41.0%, P = ns, OR = 3.59), while in the long survivors group the HLA- Bw4/Bw4 specificity increased when compared to dead patients (23.0% vs. 0%, P = ns). Moreover, we observed that six of the seven dead patients had HLA-DQB1∗05; the phenotypic frequency of this HLA allele, in dead and long survivors patients, was 85.7% and 23.0% respectively (P = 0.004; OR = 20). Conclusion Our observations suggest that the presence of the HLA-DQB1∗05 alleles characterizes the patients with the poorest prognosis in MF. In addition, absence of the KIR-ligand epitope HLA-B Bw4 showed a trend of being more prominent in MF patients with the poorest prognosis.

AB - Background Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma. We previously reported that the prognosis of MF patients is not only related on clinical variables but it is also associated with peculiar HLA alleles. Until today, the association of HLA ligands for KIR with the prognosis of the disease has not yet been analysed. Objective We investigated the frequency of HLA ligands for killer cell Immunoglobulin-like receptors (KIRs) in MF patients, evaluating if the presence of particular HLA alleles that are ligands for KIR may have prognostic value. Methods The study includes 46 Caucasian MF patients that, between 1993 and 1997, underwent HLA genomic typing. All patients were diagnosed and followed up from 1977 to 2012 (mean follow-up of 11 years). Results MF patients have been divided into two groups (long survivors and dead patients). We noticed that the HLA-Bw6/Bw6 specificity increased among the group of seven dead patients compared to the group of 39 long survivors (71.4% vs. 41.0%, P = ns, OR = 3.59), while in the long survivors group the HLA- Bw4/Bw4 specificity increased when compared to dead patients (23.0% vs. 0%, P = ns). Moreover, we observed that six of the seven dead patients had HLA-DQB1∗05; the phenotypic frequency of this HLA allele, in dead and long survivors patients, was 85.7% and 23.0% respectively (P = 0.004; OR = 20). Conclusion Our observations suggest that the presence of the HLA-DQB1∗05 alleles characterizes the patients with the poorest prognosis in MF. In addition, absence of the KIR-ligand epitope HLA-B Bw4 showed a trend of being more prominent in MF patients with the poorest prognosis.

UR - http://www.scopus.com/inward/record.url?scp=84956673465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956673465&partnerID=8YFLogxK

U2 - 10.1111/jdv.13083

DO - 10.1111/jdv.13083

M3 - Article

VL - 30

SP - 266

EP - 269

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 2

ER -